Marshall Urist

Dr. Urist Joined Royalty Pharma in 2013. Previously, Dr. Urist was an executive director and the senior biotechnology analyst at Morgan Stanley. Dr. Urist has a BA, Phi Beta Kappa, from Johns Hopkins University, a PhD from Columbia University, and an MD from Columbia University.